The Ketogenic Diet: How Ketosis Works and Who Benefits

A Metabolic State the Body Has Always Known

Long before the ketogenic diet became a weight-loss trend, it was a medical therapy — developed in the 1920s at the Mayo Clinic by physician Russell Wilder to treat epilepsy in children who did not respond to the only available anticonvulsant drugs of the time. The diet fell out of clinical use when effective anticonvulsant medications arrived in the 1930s and 1940s, only to be rediscovered in the 1990s when the Charlie Foundation, established after a young boy's seizures were dramatically reduced on the diet, renewed medical interest. Today the ketogenic diet has simultaneously achieved mainstream popularity as a weight-loss strategy and retained its evidence-based medical role in epilepsy treatment.

The Physiology of Ketosis

Under normal dietary conditions, the body runs primarily on glucose — derived from dietary carbohydrates and, between meals, from glycogen stores in the liver and muscles. When carbohydrate intake is severely restricted (typically below 20–50 grams per day), glycogen stores are depleted within 24–48 hours. The brain, which cannot use fatty acids directly as fuel, requires an alternative substrate.

The liver provides it. When blood insulin levels drop (a direct consequence of carbohydrate restriction), fatty acids are mobilized from adipose tissue and transported to the liver, where they undergo beta-oxidation to produce acetyl-CoA. When acetyl-CoA accumulates faster than it can enter the citric acid cycle, it is shunted into the production of ketone bodies: acetoacetate, beta-hydroxybutyrate (BHB), and acetone. These ketones enter the bloodstream and are taken up by the brain, heart, skeletal muscle, and other tissues as fuel — a metabolic state called nutritional ketosis.

Nutritional ketosis (typically 0.5–3 mmol/L BHB) is physiologically distinct from diabetic ketoacidosis (DKA), which occurs at ketone levels above 10 mmol/L in the setting of absent insulin and hyperglycemia. Conflating the two is a common error.

Standard Macronutrient Ratios

The classic ketogenic diet was formulated with a fat-to-protein-plus-carbohydrate ratio of 4:1 by weight, meaning 90% of calories from fat, approximately 6–8% from protein, and 2–4% from carbohydrates. This strict version is used in medical settings, particularly pediatric epilepsy. Modern popular versions are less restrictive:

• Classic ketogenic diet: 90% fat, 6% protein, 4% carbohydrate (used for epilepsy)
• Modified Atkins diet: 65% fat, 30% protein, 5% carbohydrate; no calorie restriction; easier to adhere to
• Low-glycemic index treatment (LGIT): Less restrictive; carbohydrates allowed but limited to low-GI choices
• Standard ketogenic diet (popular version): Approximately 70–75% fat, 20–25% protein, 5–10% carbohydrate

Medical Applications: The Epilepsy Evidence

The strongest clinical evidence for the ketogenic diet is in refractory epilepsy — cases where seizures are not controlled by two or more anticonvulsant medications. A 2008 randomized controlled trial in The Lancet Neurology found that 38% of children on the ketogenic diet achieved a more than 50% reduction in seizure frequency compared to 6% of controls. About 7% of children on the diet achieve complete seizure freedom.

The mechanism by which ketones reduce seizures is not fully understood. Proposed mechanisms include altered neurotransmitter balance (increased GABA, decreased glutamate), reduced neuronal excitability through effects on ion channels, and anti-inflammatory effects of ketone bodies. The diet is particularly effective for glucose transporter type 1 (GLUT1) deficiency syndrome and pyruvate dehydrogenase deficiency — conditions where the brain cannot adequately use glucose, making ketones the preferred fuel.

Weight Loss and Metabolic Health

Short-term weight loss on a ketogenic diet is often rapid and substantial — largely due to glycogen depletion (glycogen is stored with 3–4 grams of water per gram), water loss from reduced insulin levels, and reduced caloric intake from restriction of palatable carbohydrate-containing foods. Metabolic adaptations include:

• Significant reduction in blood triglycerides (20–50% in clinical studies)
• Increases in HDL cholesterol
• Often significant decreases in fasting blood glucose and insulin in people with type 2 diabetes or prediabetes
• Mixed effects on LDL cholesterol — LDL particle size typically increases (larger, less atherogenic), though total LDL-C may rise or fall depending on fat quality and individual genetics

Risks, Side Effects, and Long-Term Considerations

Long-term adherence is the central challenge for the ketogenic diet as a weight-loss tool. A 2020 systematic review found no significant difference in weight loss between ketogenic and other dietary approaches at 12 months, suggesting that adherence — not the specific metabolic mechanism — drives long-term outcomes.

This article is for informational purposes only. Consult a qualified healthcare professional before making any health decisions.